N-locking stabilization of covalent helical peptides: Application to Bfl-1 antagonists

Chem Biol Drug Des. 2020 Apr;95(4):412-426. doi: 10.1111/cbdd.13661. Epub 2020 Jan 20.

Abstract

Recently, it was reported that tetrapeptides cyclized via lactam bond between the amino terminus and a glutamic residue in position 4 (termed here N-lock) can nucleate helix formation in longer peptides. We applied such strategy to derive N-locked covalent BH3 peptides that were designed to selectively target the anti-apoptotic protein Bfl-1. The resulting agents were soluble in aqueous buffer and displayed a remarkable (low nanomolar) affinity for Bfl-1 and cellular activity. The crystal structure of the complex between such N-locked covalent peptide and Bfl-1 provided insights on the geometry of the N-locking strategy and of the covalent bond between the agent and Bfl-1.

Keywords: Bcl-2 family proteins; Bfl-1; N-locked peptide; PPIs; covalent inhibitors; protein; protein interactions; stapled alpha helix.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Apoptosis Regulatory Proteins / chemistry*
  • Apoptosis Regulatory Proteins / pharmacokinetics
  • Crystallization
  • Forkhead Transcription Factors / chemistry*
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Models, Molecular
  • Nerve Tissue Proteins / chemistry*
  • Nerve Tissue Proteins / metabolism
  • Peptide Fragments / chemistry*
  • Peptide Fragments / metabolism
  • Protein Binding
  • Protein Conformation
  • Proto-Oncogene Proteins / chemistry*
  • Proto-Oncogene Proteins / metabolism

Substances

  • Apoptosis Regulatory Proteins
  • Bax protein (53-86)
  • FOXG1 protein, human
  • Forkhead Transcription Factors
  • Nerve Tissue Proteins
  • Peptide Fragments
  • Proto-Oncogene Proteins